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Abstract 
Background: Norway has achieved a noteworthy reduction in smoking prevalence over the 
past forty years. In 2015, 13% of Norwegians aged 13-74 smoked daily and a further 9% 
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smoked occasionally. One of the objectives of the Norwegian 2013-2016 national strategy 
for tobacco control is to achieve a reduction in the daily smoking prevalence to less than 
10% by 2016.  This paper aims to estimate how long it will take for Norway to achieve the 
10% smoking prevalence.  Methods: A dynamic forecasting model using smoking prevalence 
data from national survey data on the prevalence of current, former and never smokers in 
the Norwegian population from 1985 to 2012 was used to estimate future smoking 
prevalence in the Norwegian population based on a continuation of current patterns in 
smoking cessation and initiation rates.  Results: The result suggests that Norway’s smoking 
prevalence among men and women will continue to decline if current trends of smoking 
initiation and cessation continue.  Our model predicts, based on figures for 1985-2012, that 
the prevalence of current daily and occasional smoking rates combined among men and 
women will not fall below the 10% mark until 2029 for men and 2026 for women, if current 
trends continue. Conclusion:   Smoking is likely to remain an important public health issue in 
Norway for many years. New strategies are needed to accelerate the decline in smoking in 
Norway.   
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Introduction 
With a long history of tobacco control,1 Norway has achieved a remarkable reduction in 
smoking prevalence over the past forty years. The percentage of Norwegians who smoke 
daily has declined from around 43% in 1973 to 13% in 2014.2 The reduction in smoking 
prevalence has been most dramatic among men, with rates of daily smoking declining from 
51% in 1973 to 14% in 2014, while rates of daily smoking among women has declined from 
32% to 13% over the same time period.3  
Norway was one of the first countries to endorse a comprehensive tobacco control act that 
resulted in a significant decline in smoking prevalence.1 The availability of snus, a moist 
smokeless tobacco product originating in Sweden that is placed under the top lip, on the 
Norwegian tobacco market might also be of importance for the decline in smoking rates.23 
The Norwegian 2013-2016 national strategy for tobacco control includes increasing tobacco 
taxation, enforcing comprehensive advertising bans, placing graphic health warnings on 
tobacco packs, and restricting smoking in public areas and workplaces.3, 4 Norway is also 
currently considering introducing plain packaging legislation; a measure previously 
introduced in Australia in 2012 and due to be introduced in France, UK and Ireland in 2016, 
which ensures that all tobacco products are sold in standardised packs without company 
logos or colours.5  This strategy therefore aims to minimize smoking uptake by making 
tobacco products less appealing to young non-smokers and to make health warnings on 
packs more noticeable to current smokers.5, 6 
Despite a nearly 50% reduction in smoking prevalence since 2004, Norway endeavours to 
further reduce smoking prevalence. The Norwegian government has set three goals in their 
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2013-2016 national strategy for tobacco control. The most ambitious of these goals is to 
reduce the daily smoking prevalence among adults aged 16-74 to less than 10% by 2016 and 
to 6% among young people aged 16-24; and to prevent people born after 2000 from starting 
to smoke—creating a tobacco free generation.3 This 10% smoking prevalence can only be 
achieved if approximately 300,000 smokers or 43% of the current smoking population quit 
smoking. 
To estimate how long it will take for Norway to achieve the 10% smoking prevalence, we 
used a dynamic forecasting Markov model to project the future smoking prevalence based 
on a continuation of current patterns in smoking cessation and initiation rates (see Figure 
1). 
 
Methods 
Our modelling approach is an adaption of Gartner et al,7 however rather than estimating 
current uptake and cessation rates in a separate model to the dynamic forecasting model, 
we now estimate all parameters (uptake, cessation rates and the projected smoking 
prevalence) concurrently in the one model, which reduced the uncertainty in the projected 
smoking prevalence estimates. However, this method meant it was not possible to combine 
the men and women into the one model as it was not possible to run two independent 
minimisation routines concurrently in the one model (one for women and one for men) and 
hence separate models for men and women were built.  
The models were constructed in Microsoft Excel (Microsoft, Redmond, Washington, USA) 
using: (1) demographic data from Statistics Norway on the population size in 1-year age 
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bands for men and women in the baseline year of 1985; (2) year-specific probabilities of 
dying at each age for men and women; (3) national survey data on the prevalence of 
current, former and never smokers in the Norwegian population from 1985 to 2012; (4) age-
specific and sex-specific relative risks of dying in current and former smokers compared to 
never smokers from the American Cancer Society’s Cancer Prevention Study II (CPSII) (M 
Thun, personal communication).  We used Monte Carlo simulation implemented with 
Ersatz,8 add-in software for Excel to estimate the cessation rates and to determine the 
uncertainty in the estimated projections. 
 
Observed current and former smoking prevalence 
We used national survey data on the prevalence of current and former smoking in men and 
women in 1-year intervals from 1985 to 2012 in the age groups 20-24,….60-64, 64-69 and 
70-79 (see Supplementary Tables 1 and 2).2 Current smokers included daily and occasional 
smokers; former smokers were former daily smokers; and never smokers included never 
and former occasional smokers who had never smoked daily. The effect of this 
categorisation was examined in sensitivity analyses by recalculating the model with the 
following categories: current smokers including only current daily smokers; former smokers 
including former daily smokers and all current occasional smokers and never smokers 
including never smokers and former occasional smokers (see Appendix). The distribution in 
each survey year over the three states of current, former, and never smokers was assumed 
to have a Dirichlet distribution,9 with the numbers as observed in the surveys as 
parameters. 
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As in Gartner et al,7 the model assumed that all smoking uptake occurs at age 20, because 
adolescents who commence and stop smoking before age 20 are unlikely to incur smoking-
related health risks. The observed prevalence of current smoking in 20–24 year olds was 
used to determine the proportion of 20 year olds who took up smoking. The forecasted 
proportion of 20 year olds taking up smoking for 2013 onwards was estimated by fitting a 
linear equation to the prevalence of current smoking from 2001-2012 in the 20-24 age 
group. The annual change from this equation expressed as a relative risk is used to project 
the future current smoker proportions. 
Probability of dying in never, former and current smokers 
The sex-specific and year-specific mortality rates for never, current, and former smokers 
were determined from the mortality rate in the total population, the prevalence of current 
and former smoking in the population and the relative risk of dying in current and former 
smokers from the CPSII study (see Supplementary material). The age-specific and sex-
specific probability of dying among never smokers was assumed to remain constant from 
2012 onwards.  
The population numbers and numbers of deaths (and consequently the mortality rates) are 
assumed to not have uncertainty since these are whole population observations and not 
samples. The relative risks of dying are assumed to have a lognormal distribution as 
implemented in the Ersatz ErRelativeRisk function. This function takes the RR and the 
SE[ln(RR)] as parameters. The function implements a correction which ensures that the 
average of the returned random RRs equals RR (instead of RR+0.5 SE[ln(RR)]2).10  
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Number of never, current and former smokers 
For the years 1985-2012, the number of men and women in the Norwegian population alive 
at each age from 0 to 100+ was obtained from Statistics Norway.11 The population was 
divided into three groups: current, former, and never smokers. The prevalence in each 
group was estimated from the prevalence of current and former smoking at each age in 
national survey data.  After the baseline year (1985), each of these subpopulations was 
followed according to a Markov process (see Figure 1). The number of never, current and 
former smokers at each age and in the years following the baseline year, was then 
estimated from (1) the number of each cohort in the preceding year, (2) the probability of 
death among never, current and former smokers; and (3) the proportional change in  
current smoking (see Appendix). Yearly births were added to the model from 1985 to 2012, 
with projected births added from 2013 to 2035.  
[Insert Figure 1 here - Overview of the Markov model7] 
Cessation rates 
The cessation rates for each 5 year age group starting from 20-24 until 70-79 years in two 
time periods (1985-2000 and 2001-2012) for men and women were estimated using the 
method of weighted least squares. This procedure selected the set of cessation values that 
reproduced as closely as possible the observed past prevalence of smoking from 1985 to 
2012. In order to account for the different sample sizes in each of the surveys we used the 
inverse of the variance of the observations to weight the observed smoking prevalence 
estimates in each year. In the Monte Carlo simulation, at each iteration, random numbers 
were drawn from the distributions of all the parameters in the model. Next, the Down-hill 
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Simplex method was used to fit the cessation rates and the linear equation such that the 
model's outcomes closely reproduced the randomly drawn survey numbers. The fitted 
values for the 2001-2012 cessation rates were then used to calculate the model outcomes 
(the projected number of current, former and never smokers for 2013-2035) for that 
iteration. The procedure was repeated 2000 times. The resulting distributions of the 
cessation rates were plotted as histograms that revealed the distributions approximated a 
bell-curve.  
Rate of decline in smoking initiation 
We determined the average yearly decline in smoking initiation in 20 year olds between 
2001 and 2012 for men and women separately from the linear regression line through the 
observations in the national survey data from 2001 to 2012. 
Prevalence projections 2013-2035 
The projected number of current, former and never smokers for each year from 2013 to 
2035 was calculated for men and women using the estimated age-specific and sex-specific 
cessation rates for 2001-2012.  
 
Results 
Cessation rates and decline in smoking initiation 
The estimated yearly rates of decline in rate of smoking initiation among 20 year olds and 
cessation rates are shown in Table 1 (with lower and upper limits of the 95% UIs). Positive 
rates indicate a net overall decline in smoking prevalence in that age group in that time 
period, while negative rates indicate an increase. In men, the initiation rates steadily 
9 
 
 
 
 
declined during the period 2001-2012, however, during the period 1985-2000 the initiation 
rate was almost stable. Women showed a decline in initiation rate within both periods but 
higher rates in 2001-2012. In both men and women, the cessation rate was highest in the 
70-79 years age group in period 2001-2012.  
[Insert Table 1 here - Yearly smoking cessation rates and annual decline in initiation rates] 
Model fit 
The model produced a good fit of the estimated smoking prevalence for 1985-2012 to the 
observed values from the survey data as indicated by R2 of 0.933 for male smoking 
prevalence and R2 of 0.932 for female smoking prevalence (see Figure 2). 
[Insert Figure 2 here - Smoking Prevalence in Men and Women from 2001 until 2012] 
Forecasting results 
Under the assumption that current trends in cessation and initiation rates will continue 
unchanged in Norway, our model predicts that smoking prevalence in men aged 20+ to fall 
to 19% (95% UI 18 % - 20%) in 2016 and to 7% (95% UI 4%- 9%) by 2035. For women, the 
model predicts 17% (95% UI 16%-18 %) smoking prevalence in the population aged 20+ by 
2016 and 5% (95% UI 3%-6%) in 2035 (See Figure 3). 
[Insert Figure 3 here - Projected Smoking Prevalence in Men and Women] 
 
Discussion 
Our model suggests that the reduction in Norway’s smoking prevalence among men and 
women, observed since 1973, will continue to decline if current trends of smoking initiation 
and cessation continue.  However, smoking will not fall below the 10% mark until 2029 for 
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men and 2026 for women. Our model also predicted the prevalence of current smoking 
rates for 2016 among men and women as 19% and 17% respectively, or 18% overall, which 
is substantially higher than the Norwegian government’s 2016 daily smoking prevalence 
goal of 10%. However, it should be noted that we included occasional smokers in our 
definition of current smoker, while the target prevalence references only daily smokers.  We 
also ran the model with current smokers restricted to daily smokers (see Appendix). The 
forecasted current smoking prevalence rates for 2016 were 12% for men and 13% for 
women, which is still above the 10% goal. However, under this definition for current 
smoking, the model estimates that smoking prevalence will fall below the 10% mark in 2018 
for men (9.9%) and 2021 for women (9.8%). 
The reason we included occasional smokers in our definition of current smoker is that 
almost half the occasional smokers in the survey data reported a weekly intake of five or 
more cigarettes, indicating relatively high consumption. Similar to regular smoking, 
occasional smoking has been linked to a number of adverse events.  Among men, occasional 
smoking is associated with an increased risk of total mortality and cardiovascular mortality12, 
26 and increased risk of having coronary heart disease.13 Among women, occasional smoking 
is associated with reduced birth weight in children14 and greater risk of myocardial 
infarction and total mortality.15  Previous attempts to reduce smoking prevalence have 
focused mainly on daily smokers as the highest risk group while neglecting occasional 
smokers.  Consequently, occasional smoking prevalence has remained stable at around 10% 
for the last 30 years.2 The no safe cigarette “smoking-non-smoking” campaign, introduced in 
January 2013, specifically targeted occasional smokers and was a good initiative by the 
11 
 
 
 
 
Norwegian government to reduce the number of occasional smokers.16 
New strategies are needed to accelerate the decline in smoking in Norway.  A promising 
strategy is the introduction of standardised tobacco packaging or plain packaging by the 
Norwegian Ministry of Health and Care Services in 2015.17  It is suggested that the 
introduction of mandatory plain packaging for tobacco products would: reduce the 
attractiveness of tobacco products;18, 19 increase the noticeability of health warnings and 
messages;20 and reduce smokers’ misperceptions about the harmfulness of tobacco 
products as pack branding features such as colours are used to convey messages of reduced 
harm, such as lighter pack colours used to signify 'light' cigarettes.21 Studies in Australia, the 
first country to introduce plain packaging in 2012, showed that the introduction of plain 
packaging of cigarettes coupled with larger graphic health warnings has reduced the appeal 
of smoking among adolescents and adults.6, 19 Plain packaging also contributes to making 
the image of smoking less positive which has the potential to reduce smoking uptake among 
adolescents.22 
In addition, harm reduction strategies (e.g. switching from cigarettes to nicotine 
replacement therapy, snus or e-cigarettes) offer an additional approach that could 
encourage adults to quit or reduce their smoking.  In Norway, the decline in smoking has 
been paralleled by an increase in the use of snus.  In 2014, the percentage of daily snus use 
was 9%, a 33% increase from 2004.23 Snus could contribute to the decline in smoking 
prevalence via two main pathways, either as a tool to assist quitting amongst smokers or as 
an alternative nicotine product for tobacco-prone youth.23 Further, some studies have 
suggested that snus is a more effective cessation aid compared to other pharmacological 
12 
 
 
 
 
nicotine products.23 There is also a growing body of research that demonstrates the 
potential role of e-cigarettes as a cessation tool.24  Cobb et al (2015)25 has recently 
developed a Markov model to operationalize the complex states and transitions that must 
be examined simultaneously and dynamically over time to determine the impact of 
alternative nicotine products such as snus and e-cigarettes.  
Limitations  
In our model, we were only able to estimate gender-specific smoking prevalence, rather 
than a combined overall prevalence.  Unlike the definition of current smoking used in 
government estimates of smoking prevalence which includes only daily smokers, we 
included occasional smokers as well which produced higher estimates for the prevalence of 
current smoking. How best to define a current smoker is not clear.  In terms of health 
outcomes, regular occasional smoking (e.g. weekly) will still confer substantial health risks 
and hence reducing this low-rate of smoking in the population is also important.26, 27  
Our modelling also looked only at net cessation, and therefore did not explicitly model 
people who take up smoking after the age of 20, or people who repeatedly quit and relapse. 
The former group will be small and will therefore not affect results much. The latter group is 
larger but will on balance probably be captured either in the former or current smoker 
groups. The excess risk of dying is modelled simply as a relative risk for current and former 
smokers. In reality, smoking-related mortality depends on a large number of variables such 
as number of smoking years, smoking intensity, time since quitting, etc. However, the 
simple approach we took is sufficiently precise for the purpose of projecting the future 
smoking prevalence, the main determinants of which are the initiation rate and the 
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cessation rates. Our Markov model also only examined one tobacco product (cigarettes) and 
did not include other forms of tobacco, such as snus, or non-tobacco nicotine products, such 
as e-cigarettes. 
 
Conclusion 
Norway’s smoking prevalence will continue to decline if the current rates of initiation and 
cessation are maintained. However, based on a continuation of current smoking and 
initiation patterns, smoking will remain an important public health issue in Norway for some 
time to come.  More and new strategies are needed to increase cessation in current 
smokers and to lower the initiation rates. 
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Key points 
 A dynamic forecasting model shows that smoking prevalence in Norway will 
continue to decline 
 The smoking prevalence will not fall below 10% until 2029 for men and 2026 for 
women 
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 Smoking will remain an important public health issue in Norway for years to come 
and new strategies are needed to accelerate the decline in smoking.  
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Table 1 
Yearly smoking cessation rates and annual decline in initiation rates 
 
1985–2000 (95% UI) 2001–2012 (95% UI) 
Men: 
  
Decline in initiation in 20-years old 0.0009 (−0.0055 to 0.0074) 0.0111 (0.0001–0.0218) 
Cessation in 20–24 years old 0.0088 (0.0043–0.0132) 0.033629 (0.0259–0.0395) 
Cessation in 25–29 years old −0.0204 (−0.0267 to − 0.0158) 0.096575 (0.0939–0.0988) 
Cessation in 30–34 years old 0.0083 (0.0008–0.0142) 0.082996 (0.0638–0.0889) 
Cessation in 35–39 years old 0.0210 (0.0151–0.0262) 0.064008 (0.0473–0.0721) 
Cessation in 40–44 years old −0.0027 (–0.0095–0.0029) 0.044191 (0.0342–0.0570) 
Cessation in 45–49 years old 0.0279 (0.0204–0.0341) 0.050093 (0.0401–0.0628) 
Cessation in 50–54 years old 0.0302 (0.0223–0.0373) 0.055179 (0.0376–0.0645) 
Cessation in 55–59 years old −0.0234 (−0.0382 to − 0.0121) 0.011287 (−0.0073–0.0215) 
Cessation in 60–64 years old 0.0995 (0.0936–0.1025) 0.095136 (0.0923–0.0983) 
Cessation in 65–69 years old −0.0639 (−0.0821 to − 0.0492) 0.059645 (0.0189–0.0717) 
Cessation in 70–79 years old 0.0306 (0.0204–0.03949) 0.114577 (0.1121–0.1172) 
Women: 
  
Decline in initiation in 20-years old 0.0002 (−0.0059 to 0.0063) 0.0173 (0.0068–0.0278) 
Cessation in 20–24 years old 0.0032 (−0.0007 to 0.0083) 0.0450 (0.0369–0.0517) 
Cessation in 25–29 years old −0.0134 (−0.0206 to − 0.0079) 0.1077 (0.1054–0.1098) 
Cessation in 30–34 years old 0.0004 (−0.0066 to 0.0061) 0.0709 (0.0571–0.0769) 
Cessation in 35–39 years old 0.0182 (0.0128–0.0232) 0.0555 (0.0453–0.0692) 
Cessation in 40–44 years old −0.0044 (−0.0118 to 0.0013) 0.0716 (0.0573–0.0794) 
Cessation in 45–49 years old 0.0189 (0.0111–0.0259) 0.0263 (0.0101–0.0369) 
Cessation in 50–54 years old 0.0218 (0.0135–0.0299) 0.0779 (0.0561–0.0834) 
Cessation in 55–59 years old 0.0098 (−0.0022 to 0.0227) 0.0507 (0.0282–0.0593) 
Cessation in 60–64 years old 0.0533 (0.0429–0.0648) 0.1052 (0.1052–0.1052) 
Cessation in 65–69 years old −0.0240 (−0.0508 to − 0.0069) −0.0253 (−0.0739 to − 0.0017) 
Cessation in 70–79 years old −0.0142 (−0.0264 to − 0.0061) 0.1287 (0.1259–0.1313) 
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Figures 
Figure 1 Overview of the Markov model8 
 
 
 
Figure 2 Smoking prevalence in men and women from 2001 until 2012 
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Figure 3 Projected smoking prevalence in men and women 
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Supplementary File 1 
 
APPENDIX 1 
Calculation of probability of dying in never, current and former smokers 
The age-specific, sex-specific and year-specific probabilities of dying (q) in the total Norwegian 
population were converted to a mortality rate using the following formula: 
𝑚𝑡𝑜𝑡𝑎𝑙𝑡,𝑎 = −ln⁡(1 − 𝑞𝑡𝑜𝑡𝑎𝑙𝑡,𝑎) 
22 
 
 
 
 
Where,  
         𝑚𝑡𝑜𝑡𝑎𝑙𝑡,𝑎  
is the mortality rate in the population aged a at time t 
               𝑞𝑡𝑜𝑡𝑎𝑙𝑡,𝑎  
is the probability of dying in the total population aged a at time t (obtained from Norwegian 
Directorate of Health, Statistic Norway) 
The sex-specific, age specific and year specific mortality rates for never, current and former smokers 
were determined by: 
𝑚𝑛𝑒𝑣𝑒𝑟𝑡,𝑎  
𝑚𝑡𝑜𝑡𝑎𝑙𝑡,𝑎
𝑅𝑅𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑎⁡ ×⁡𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎⁡⁡ ⁡× ⁡𝑅𝑅𝑓𝑜𝑟𝑚𝑒𝑟𝑎⁡⁡ ×⁡𝑃𝑓𝑜𝑟𝑚𝑒𝑟𝑡,𝑎⁡ + 1 − (𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎 +⁡𝑃𝑓𝑜𝑟𝑚𝑒𝑟𝑡,𝑎⁡)
 
 
  𝑚𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎⁡=⁡𝑅𝑅𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑎 ×𝑚𝑛𝑒𝑣𝑒𝑟𝑡,𝑎 
                𝑚𝑓𝑜𝑟𝑚𝑒𝑟𝑡,𝑎⁡=⁡𝑅𝑅𝑓𝑜𝑟𝑚𝑒𝑟𝑎 ×𝑚𝑛𝑒𝑣𝑒𝑟𝑡,𝑎 
Where 
𝑚𝑛𝑒𝑣𝑒𝑟𝑡,𝑎 
                                                    
is the mortality rate in never smoked at age a, time t. 
𝑅𝑅𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑎 
is the relative risk of dying in current smokers compared to never smokers from Cancer Prevention 
Study II (CPSII) at age a. 
𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎 
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is the prevalence of current smokers in the population at age a, at time t. 
                         
𝑅𝑅𝑓𝑜𝑟𝑚𝑒𝑟𝑎 
               
is the relative risk of dying in former smokers compared to never smokers from CPSII at age a 
𝑃𝑓𝑜𝑟𝑚𝑒𝑟𝑡,𝑎 
                                                       
 
is the prevalence of former smokers in the total population at age a, at time t. 
The mortality rates were then converted to the probability of dying at age a and time t according to: 
𝑞𝑡,𝑎 = 1 − 𝑒
(−𝑚𝑡,𝑎) 
Calculation number of never, current and former smokers at each age in the model 
The number of never, current and former smokers at each age and in the years following the 
baseline year is determined according to: 
𝑁𝑒𝑣𝑒𝑟𝑡,𝑎 = 𝑁𝑒𝑣𝑒𝑟𝑡−1,𝑎−1 ⁡× (1 − 𝑞𝑛𝑒𝑣𝑒𝑟𝑡−1,𝑎−1) 
𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎 = 𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡−1,𝑎−1 ⁡× (1 − 𝑞𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡−1,𝑎−1) × (1 − 𝐶𝑡−1,𝑎−1) 
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡𝐹𝑜𝑟𝑚𝑒𝑟𝑡,𝑎 = 𝐹𝑜𝑟𝑚𝑒𝑟𝑡−1,𝑎−1 ⁡× (1 − 𝑞𝑓𝑜𝑟𝑚𝑒𝑟𝑡−1,𝑎−1) 
+𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡−1,𝑎−1 ⁡× (1 − 𝑞𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡−1,𝑎−1) − 𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎 
Except for age 20, which was determined according to: 
  𝑁𝑒𝑣𝑒𝑟𝑡,20 = 𝑁𝑒𝑣𝑒𝑟𝑡−1,19 ⁡× (1 − 𝑞𝑛𝑒𝑣𝑒𝑟𝑡−1,19) × (1 − 𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡,20) 
 𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡,20 = 𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡−1,19 ⁡× (1 − 𝑞𝑛𝑒𝑣𝑒𝑟𝑡−1,19) × (𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡𝑡,20) 
Where:  
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                                        𝐶𝑢𝑟𝑟𝑒𝑛𝑡𝑡,𝑎 
is the number of current smokers in the population at age a at time t 
                                          𝐹𝑜𝑟𝑚𝑒𝑟𝑡,𝑎 
is the number of former smokers in the population at age a at time  
                                       𝑁𝑒𝑣𝑒𝑟𝑡,𝑎 
is the number of never smokers in the population at age a at time t 
                                              𝐶𝑡,𝑎 
 is the proportional change in current smoking prevalence at time t and age 
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Supplementary File 2 
Supplementary Table 1: Observed prevalence of current smoking between 1985 and 2012 in Norway men aged 20+ years 
 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 
Age:               
20-24 0.546 0.453 0.461 0.466 0.468 0.419 0.586 0.510 0.506 0.473 0.52 0.533 0.500 0.533 
25-29 0.556 0.629 0.480 0.500 0.465 0.509 0.541 0.527 0.451 0.538 0.506 0.512 0.480 0.449 
30-34 0.614 0.564 0.602 0.570 0.559 0.542 0.491 0.576 0.614 0.557 0.440 0.561 0.574 0.447 
35-39 0.548 0.558 0.563 0.593 0.565 0.486 0.488 0.531 0.616 0.563 0.429 0.487 0.508 0.421 
40-44 0.594 0.480 0.500 0.534 0.400 0.594 0.537 0.491 0.542 0.513 0.478 0.529 0.486 0.429 
45-49 0.610 0.541 0.492 0.541 0.438 0.515 0.484 0.596 0.527 0.398 0.536 0.444 0.500 0.485 
50-54 0.389 0.443 0.478 0.556 0.430 0.412 0.417 0.423 0.547 0.387 0.368 0.491 0.448 0.508 
55-59 0.551 0.473 0.486 0.540 0.532 0.417 0.353 0.426 0.508 0.434 0.243 0.600 0.343 0.326 
60-64 0.446 0.386 0.436 0.449 0.527 0.407 0.415 0.426 0.404 0.368 0.263 0.400 0.471 0.222 
65-69 0.481 0.481 0.489 0.440 0.354 0.395 0.25 0.366 0.42 0.365 0.300 0.386 0.419 0.222 
70-79 0.299 0.314 0.343 0.456 0.433 0.414 0.317 0.365 0.211 0.263 0.383 0.344 0.394 0.208 
Overall 0.528 0.498 0.493 0.517 0.491 0.475 0.466 0.486 0.499 0.457 0.425 0.491 0.478 0.419 
 
 
 
 
 
              
 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Age:               
20-24 0.400 0.521 0.415 0.458 0.328 0.435 0.356 0.414 0.341 0.395 0.255 0.471 0.320 0.222 
25-29 0.404 0.482 0.507 0.363 0.363 0.443 0.489 0.258 0.241 0.323 0.452 0.258 0.243 0.225 
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30-34 0.431 0.48 0.423 0.375 0.375 0.254 0.404 0.339 0.226 0.300 0.192 0.200 0.235 0.333 
35-39 0.516 0.463 0.415 0.400 0.446 0.410 0.269 0.339 0.393 0.302 0.263 0.346 0.286 0.236 
40-44 0.446 0.458 0.523 0.317 0.403 0.519 0.377 0.2279 0.292 0.339 0.308 0.164 0.226 0.229 
45-49 0.4314 0.435 0.588 0.470 0.400 0.343 0.379 0.263 0.308 0.408 0.355 0.241 0.362 0.25 
50-54 0.365 0.372 0.442 0.426 0.403 0.375 0.186 0.313 0.417 0.226 0.365 0.339 0.354 0.288 
55-59 0.390 0.417 0.404 0.355 0.500 0.292 0.327 0.289 0.421 0.207 0.313 0.348 0.314 0.302 
60-64 0.216 0.324 0.353 0.405 0.229 0.407 0.302 0.381 0.340 0.30 0.245 0.318 0.222 0.305 
65-69 0.370 0.36 0.276 0.091 0.154 0.212 0.261 0.310 0.237 0.24 0.139 0.167 0.170 0.250 
70-79 0.36 0.234 0.344 0.243 0.302 0.164 0.123 0.157 0.128 0.148 0.170 0.265 0.083 0.114 
Overall 0.406 0.420 0.443 0.369 0.367 0.356 0.321 0.302 0.310 0.286 0.278 0.283 0.260 0.253 
 
 
Supplementary Table 2: Observed prevalence of current smoking between 1985 and 2012 in Norway women aged 20+ years 
 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 
Age:               
20-24 0.597 0.432 0.485 0.453 0.519 0.466 0.408 0.471 0.420 0.449 0.493 0.444 0.492 0.564 
25-29 0.496 0.559 0.577 0.548 0.436 0.579 0.493 0.557 0.588 0.457 0.474 0.383 0.440 0.415 
30-34 0.563 0.554 0.619 0.585 0.504 0.522 0.496 0.559 0.527 0.481 0.629 0.476 0.543 0.468 
35-39 0.409 0.508 0.496 0.488 0.584 0.577 0.588 0.525 0.559 0.566 0.560 0.514 0.468 0.531 
40-44 0.440 0.445 0.436 0.487 0.535 0.512 0.464 0.461 0.48 0.425 0.56 0.478 0.5 0.389 
45-49 0.427 0.436 0.522 0.368 0.471 0.396 0.455 0.440 0.4 0.440 0.418 0.508 0.460 0.505 
50-54 0.410 0.387 0.309 0.476 0.366 0.388 0.313 0.346 0.338 0.390 0.328 0.471 0.446 0.547 
55-59 0.344 0.448 0.385 0.430 0.229 0.351 0.366 0.444 0.412 0.397 0.276 0.481 0.333 0.255 
60-64 0.337 0.278 0.326 0.375 0.294 0.395 0.274 0.261 0.367 0.294 0.278 0.25 0.225 0.25 
65-69 0.165 0.265 0.256 0.333 0.2 0.231 0.313 0.236 0.291 0.255 0.255 0.143 0.222 0.325 
70-79 0.08 0.192 0.180 0.233 0.171 0.189 0.154 0.105 0.212 0.264 0.1 0.25 0.188 0.273 
Overall 0.407 0.424 0.438 0.455 0.417 0.435 0.418 0.414 0.432 0.419 0.428 0.424 0.427 0.442 
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 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Age:               
20-24 0.490 0.477 0.403 0.433 0.404 0.371 0.433 0.295 0.459 0.346 0.327 0.40 0.195 0.178 
25-29 0.446 0.471 0.443 0.340 0.328 0.292 0.245 0.333 0.383 0.382 0.154 0.289 0.341 0.184 
30-34 0.459 0.393 0.469 0.492 0.466 0.368 0.271 0.313 0.308 0.218 0.298 0.297 0.217 0.286 
35-39 0.561 0.380 0373 0.444 0.394 0.411 0.297 0.359 0.338 0.172 0.230 0.218 0.192 0.175 
40-44 0.434 0.44 0.609 0.397 0.353 0.297 0.321 0.481 0.366 0.288 0.206 0.313 0.293 0.364 
45-49 0.606 0.357 0.468 0.467 0.384 0.466 0.302 0302 0.333 0.294 0.311 0.34 0.339 0.283 
50-54 0.5 0.340 0.36 0.480 0.418 0.358 0.370 0.373 0.365 0.481 0.3 0.375 0.322 0.378 
55-59 0.390 0.439 0.313 0.344 0.298 0.327 0.488 0.3 0.285 0.278 0.236 0.228 0.261 0.188 
60-64 0.310 0.282 0.25 0.262 0.278 0.186 0.261 0.286 0.195 0.208 0.289 0.2 0.269 0.176 
65-69 0.333 0.333 0.276 0.61 0.2 0.270 0.167 0.077 0.297 0.107 0.256 0.194 0.167 0.222 
70-79 0.154 0.170 0.176 0.2 0.206 0.119 0.140 0.138 0.107 0.185 0.118 0.2 0.083 0.158 
Overall 0.457 0.372 0.402 0.388 0.345 0.319 0.305 0.308 0.312 0.268 0.248 0.276 0.250 0.234 
